Electronic retinal implants such as the PRIMA system bypass damaged cells to restore partial central vision, bringing ...

A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition ...

An editorial published in the New England Journal of Medicine 1 referred to the Photovoltaic Retina Implant Microarray (PRIMA ...

Central vision can fade slowly with age-related macular degeneration. Faces blur. Words smear on a page. A dark spot can sit ...

An editorial published today in The New England Journal of Medicine (NEJM) writes that Science Corporation's PRIMA implant is the first treatment in clinical trials to successfully restore functional ...

Please provide your email address to receive an email when new articles are posted on . Retinal implants have a history of challenges, and questions remain about their utility. A bioengineered RPE ...

A radical stem cell transplant has significantly improved the blurry vision of three people with severe damage to their cornea. The clinical trial, which took place in Japan, is the first of its kind ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with advanced dry macular degeneration. The hair-thin patch replaces damaged retinal ...

Imagine slowly losing the center of your vision, like a camera lens fading to fog. That's what happens with geographic atrophy, a severe form of age-related macular degeneration (AMD). It's the ...

Mammals aren’t known for the ocular regenerative powers, but a new study shows that nature has a few tricks up its sleeve.

Age-related macular degeneration (AMD) is an untreatable vision loss problem impacting those over 50. The disease starts as a thinning of the macula (the part of the retina responsible for detailed ...